HHSE Due Diligence: Business Model, Form 10 & S-1

New Post Public Reply Private Reply Replies (4) Message Board
speckulater speckulater #4878
581
HHSE Due Diligence: Business Model, Form 10 & S-1 Registration




HHSE has been in existence and profitable for years. A lot of DD to get your head around. I have followed for 9+ years. HHSE just put out an Investor Relations Blog with a New Business Model and Outline. I follow that up with a description of Form 10 & S-1. What do they mean and what will happen. A lot of this material is new to even me. I suggest reading the material below, several times, until it starts to sink in and you get an idea of what is coming and when.

As always Do Your Own Due Diligence.






BLOG-11/4 (With- Three -Updates): HHSE/MyFlix Key-Events Outline & Business Model




FYI
I have been informed there was a third Addition (not just two) made to the Original BLOG. All 3 Updates are highlighted in red below. Notify me of any errors.





kcobghhseblog.png



Sunday, November 4, 2018

HHSE / MYFLIX - Outline of Key Events & Business Model

Greetings HHSE Friends & Followers - Several different versions of BLOG POSTS have been created in the past two weeks - as requested by Shareholders and "longs" wanting updates on a wide variety of issues. But, the operational distractions from current product shipments - combined with some management uncertainty about the ongoing medical status of Fred Shefte - created enough of a demand for focus as to distract from such corporate communications and shareholder updates.

With Fred Shefte now back at the office full-time, the company is able to redirect attentions towards the current issues and long-term direction. So, what are the current issues and long term goals? We will outline these as briefly as possible - as the detailed answers would comprise more than 60-pages of disclosures for a Form 10 or S-1 filing.

IMMEDIATE ISSUES

HHSE continues to service those titles that were produced, acquired or otherwise released in some manner under what management is now calling "the old business model." These title are what many in the industry would characterize as lower-tier Independent Releases - despite most having some level of theatrical visibility prior to home video or digital release.

The current titles include this TUESDAY's release of "GETTING GRACE" - which enjoyed theatrical exposure on more than 95-theatres in 35 of the top 40 markets this past Spring. Next up are the December home video releases of "RIDE UNITED" (Redbull Media House) and "AMERICA UNITED" (ABC Television), followed by a January 1st home video release of "SLEEPER CELL: THE ALGERIAN" and a February release of "THE LENNON REPORT." Three additional titles that had some level of theatrical release will follow in March, April and May - and these collectively represent "the end" of the older business model for HHSE to handle films with limited theatrical releases. Due to contractual obligations made to these producers, HHSE will follow-thru on the home video marketing of each, despite the longer term goal of phasing out of such titles.


SIDE NOTE : DVDs of "GETTING GRACE" can be pre-ordered on-line now via AMAZON or WALMART, and we encourage shareholders to help us achieve a strong week-one sales through the purchase of a copy!

AMAZON.com listing (currently at # 198 Best Seller):

https://www.amazon.com/Getting-Grace-Daniel-R...+grace+dvd

WALMART.com listing (currently WM's # 38 BEST SELLER!
https://www.walmart.com/ip/Getting-Grace-DVD/358583120


OTHER IMMEDIATE ISSUES include jump-starting some LEGAL responses that were put onto hold during Shefte's 7-week absence from the office. Specific items include: Stay of enforcement and re-opening of cases for JSJ and Bedrock; Catch-Up on structured settlement payments with CD Video, GDC, and Ackerman; Countersuit against Crimson and pre-Form 10 settlements with other significant creditors (including Graham, Andersons and Southwinds).

HHSE / MYFLIX ONGOING BUSINESS MODEL? With management having determined that the lower-end titles are cash-intensive, time-consuming and deliver only a very marginal revenue upside, the goal has been to identify specific areas within the entertainment industry where a company such as Hannover House can excel. For this reason, the company determined that the best strategy for maximizing revenues and bottom line results is a two-pronged approach: Major Films for HHSE and MyFlix as a one-stop digital streaming store.

By "Major Films" we mean that the company plans to release FOUR (4) features per year that have high-profile casts and which deserve (and get) broad theatrical distribution (500 or more locations). The first of these "Major Films" is a feature that's 95% completed at this time, and which HHSE plans to release in early MARCH, 2019. This title has NOT yet been announced.


It is management's belief that MOST of the titles comprising these four annual tent-poles will ultimately need to be PRODUCED by (or with the assistance of), HHSE in the Studio capacity. This is because at the film festival circuit level - generally speaking - any film of commercial merit has either been pre-sold to the major studios or ends up sparking a bidding for for the acquisition of rights (and HHSE cannot realistically expect to compete against the current acquisitions funding of Amazon, Netflix or the Major Studio specialty divisions). To get these "Major Films" - HHSE is likely going to have to act as a catalyst to spark the production. A good example of how this might occur is listed below (see "MELTDOWN" .

With respect to MYFLIX - while the on-boarding of titles continues at full speed (now at 1,168 titles) -
FULLY WITH MASTERS, as opposed to 2,100 with "only Metadata" and not fully with conformed masters) - and acquisition of more studio supplier partners continues (now representing well in excess of 10,000 titles) - the actual consumer launch of the site does not look likely for the next few weeks. We are now going into the insane HOLIDAY season for ads and digital media, creating both a shortage of promotional inventories and a spike in costs. The cost for 30-second TV Ads on national cable (for instance), drops by more than 50% after January 1st... which also corresponds with terrific cold-weather, indoors-type seasonality (perfect for our MyFlix launch - and also corresponds with when we will surpass the 2,500 titles ON BOARDED level).

FINANCING FOR "MAJOR FILMS & MYFLIX" - Some shareholders have asked (rightfully so) how a company (that has been horribly cash-strapped from its stubborn focus on indie films for video release) anticipates financing this ambitious involvement in the "Major Films" as well as in the competitive world of launching a major MyFlix site?

Here's how:


1). FORM 10 REGISTRATION - The long-awaited filing of the company's registration statement is the first step in the company's overall new launch. Large funds and investors that have been hesitant (or prohibited) from supporting HHSE as a Pinksheet stock will now be able to invest in HHSE shares. Management anticipates that the act of filing the Form 10 could (and should) result in a PPS of $.03 or higher. The Form 10 may be filed in the next few weeks, and the impact to the HHSE share price might be seen immediately - even though the S.E.C. has 60-days to provide "comments" requiring the issuer's response.

2). P&A FUNDS SECURED AGAINST VIDEO / V.O.D. - HHSE has been working with a proven P&A funder for a structure which provides substantial (multi-million dollar) traunches of theatrical release support for qualifying titles under a major studio Video / V.O.D. assignment. HHSE will enjoy the benefits (and upfront fees) from the marketing of titles under this P&A structure - as well as earned sales fees from theatrical settlements. Furthermore, the assignment of video rights to the major studio partner relieves HHSE of the need for substantial video staff and manufacturing funds.

3). CO-PRODUCTION PARTNERS, INTERNATIONAL PRE-SALES, INCENTIVES AND "GAP" - With respect to the facilitation of a major feature film - such as "MELTDOWN" - the assembly of financing for this $10-mm production in many ways is easier than raising $500,000 for a small indie production. Why? Well, first of all, having three major stars in "MELTDOWN" provides pre-sale interest for the receipt of bankable licensing agreements. Next, the higher stature also encourages greater support from State Incentive programs, and finally the existence of significant pre-sales can be leveraged to obtain what is known as "Gap" financing in the entertainment industry (e.g., a bank loan for "the gap still needed" - secured against the unsold territories). We also may bring in "co-production partners" for a portion of financing or in-kind services, as a variation on the pre-sale model.

For Major feature films structured in this manner - in which HHSE has essentially "packaged" the financing elements and performed the Executive Producer or Studio function - there will be significant fees paid to HHSE upfront... as well as certain assignable allocated overhead expenses. Additionally, after completion of the production, HHSE will launch the films to theatres under the P&A structure described above - also generating operating overhead through marketing fees, booking services and sales settlements.


4). S-1 REGISTRATION - HHSE has been in discussions with three significant parties that have expressed support of buying HHSE shares under a S-1 Shelf Registration (simultaneous with the Form 10, or almost immediately thereafter). As presently envisioned, the S-1 would be launched in January with a total potential sale of up to 90-mm HHSE shares made available, with a base price anticipated in the $.045 range, and going all the way up to $.10 for the final traunch of shares. HHSE anticipates raising about $4.5-mm in direct operating capital - while only diluting the total A/S by 10% or less. These direct funds will provide marketing support for MyFlix - as well as cash-flow flexibility for assisting with the development of the tent-pole Major Films and other ongoing operations. The anticipated buyers of the S-1 offering are long-term, strategic partners, and are not expected to sell any of their shares in the first year or two. The structure of the S-1 incentivizes earlier subscribers, as the price per share increases as the inventory of S-1 shares is diminished. The base price of the first traunch of S-1 shares is being established to be at a level estimated to start at 150% of the VWAP of the HHSE shares - which means that these new shareholders are buying equity at a significant premium "above" market. The S-1 Registration will be filed shortly after the Form 10, as the company will await any initial feedback and comments to the registration statement.

As stated above - the more specific details for each of these major activities for HHSE requires more than a summary blog. But the information above provides a good outline of where we are, and where we are going.

Yes, it's GREAT that a movie like "GETTING GRACE" is listed as a BEST SELLER for Walmart.com... who knows? Maybe it will hold its shelf placements through Black Friday (as per the HHSE marketing plan), and ultimately deliver a wonderful Q4 for HHSE? But long-term, it's the expectation that FOUR "Major Films" could deliver $100-mm in revenues... as can MYFLIX... that is the driving force for this well-planned reinvention of the company's operating model!

STAY TUNED!






The GETTING GRACE international sales activities launched this week at the AMERICAN FILM MARKET in Santa Monica, CA. To better conform to international packaging tastes, a different key art campaign was developed.


http://hannoverhousemovies.blogspot.com/2018/...vents.html






Myflix-Image.jpg









Form-10 & S-1 Registrations: Uplist-OTC:QB, $4,500,000-Cash-Infusion, HHSE $.045-$.10


HHSE FORM 10 REGISTRATION

* Detailed Document (40 - 60 Pages) Essential HHSE Stock Information
* Audited Financial Statements
* Descriptions, Potential Opportunities & Conflicts of Interest
* Filed with SEC & Stored on EDGAR
* After 60 Day Review, HHSE Becomes SEC-Compliant
* HHSE Uplists To Higher Stock Exchange OTC:QB
* ~ $.03



HHSE S-1 REGISTRATION

* Direct Stock Purchase (Accredited Investor Buy Directly From HHSE)
* Cash Infusion (Unlike Market Buys, Monies Go Directly To HHSE Coffers)
* 150% of the VWAP of the HHSE shares
* Significant Premium "ABOVE" Market
* $.045 - $.10
* Potential $4,500,000
* Accretion, NOT Dilution
* HHSE Treasury Available For Corporate Investment

















HHSE





















Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fault Codes vs. Diagnosis: What's the Real Fix?

Updated Category News Views 8

When a Blink Isn’t the Whole Story Ever sat in your car, watched that check engine light flicker on, and felt your heart drop? Yeah, we've all been there. But here’s the kicker: just ‘cause that little demon’s glowing doesn’t mean your mechanic’s got all the answers. That’s where this HelloNation article steps in, trying to shed some light on the difference...

Continue Reading
Altitude+ and ViewLift Celebrate Record Fan Engagement

Updated Category News Views 38

Fresh Off the Bench: Altitude+ Rises Picture this: you're cruising through October, watching the leaves fall and the puck drop, and here come Altitude+ and ViewLift boasting some record numbers. This ain't your everyday puff piece — they've got concrete results to back it up. Altitude+, charging into the 2026–27 NHL and NBA seasons, isn't just surviving; they're...

Continue Reading
Venezuelan Crude Hits Texas: NABEP's Bold Move

Updated Category News Views 0

Venezuelan Crude Docking in Texas Signals New Energy Dynamics Batten down the hatches, 'cause NABEP's Venezuelan crude has made a splashy arrival in Texas. We're talking 1 million barrels, folks, the first of its kind under a fresh U.S. deal. This ain't your grandpa's oil shipment from the Middle East that takes forever to get here—nope, this crude made a pit stop in...

Continue Reading
Heart Attack vs. Cardiac Arrest: Know the Differences

Updated Category News Views 0

Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...

Continue Reading
Lincoln Educational Faces Class Action for Stock Drop

Updated Category News Views 68

What's Gripping Lincoln Educational Services? You ever feel like you've stepped into a financial thriller with these education stocks? Well, Lincoln Educational Services (NASDAQ:LINC) is at the heart of one, facing the heat of a class action lawsuit filed by Bleichmar Fonti & Auld LLP. It's all about securities fraud—a dreaded term that no investor wants to hear. The...

Continue Reading
Yuchai Eyes African Market Expansion with Strategic Visits

Updated Category News Views 65

Yuchai's Bold Move into Africa There's something gutsy about a company that doesn't just sit on its achievements but heads out into new territories. China Yuchai International (NYSE: CYD), a big player in powertrain solutions, recently embarked on a strategic tour across the African continent, a move that could well shape their future market playbook. East Africa:...

Continue Reading
Americans' Faith in Democracy Hits New Lows

Updated Category News Views 36

Polarization Beyond Politics: A National Reckoning When you catch wind of a report like this one, it's enough to make you feel like the fabric of democracy is unraveling right before our eyes. We're staring at a national identity crisis, folks, and it's got nothing to do with whether you're waving a red or blue flag. This ain't about party lines; it's about a bigger,...

Continue Reading
Franklin Financial Q3: 59% Net Income Surge Amid Growth

Updated Category News Views 80

Soaring Net Income and Impressive Growth Franklin Financial Services Corporation (NASDAQ: FRAF) seems to be on a roll this year, painting a vivid picture of growth as they close out the third quarter of 2026. With a strong surge in net income—59.4% up from Q3 2025—this leadership in earnings is no fluke. Net Income and Earnings per Share Let's break it down: the...

Continue Reading
Alpheus Explores LDH Kinetics as Glioblastoma Biomarker

Updated Category News Views 40

Cracking Glioblastoma's Tough Shell Some days, you're slogging through numbers that don't add up, and other times, you stumble upon findings that just might change the game. Alpheus Medical, diving headfirst into the murky waters of glioblastoma, dropped some intriguing data at the ESMO Congress 2026. This isn't your usual round of clinical discoveries, folks. What...

Continue Reading
Post University Expands with New Tech and Health Degrees

Updated Category News Views 56

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Continue Reading

Top 5 Most Recently Viewed Articles

T1D Fund's Major Capital Raise for Revolutionary Diabetes Solutions

Updated Category News Views 181

Launch of a Transformative Capital Raise by the T1D Fund The T1D Fund has embarked on an exciting new fundraising initiative designed to supercharge investment in groundbreaking solutions for type 1 diabetes (T1D). This fundraising campaign is tailored to stimulate larger, more substantial investments in innovative T1D programs, thanks to the Fund's renowned track record...

Continue Reading
NEST Center's Exciting Renovation Plans Unveiled for Tenants

Updated Category News Views 217

Major Renovation Kickoff at the Northeast Science & Technology Center The Northeast Science & Technology (NEST) Center is launching an ambitious renovation project, aimed at enhancing over 75,000 square feet of shared amenities designed to foster a vibrant ecosystem of research and innovation for both current and future tenants. Innovative Vision for the NEST Center...

Continue Reading
Understanding Tryg's Share Buyback Programme Dynamics

Updated Category News Views 198

Detailed Insights on Tryg's Share Buyback Programme In a strategic move, Tryg A/S has initiated a robust share buyback programme aimed at enhancing shareholder value. This initiative, valued at up to DKK 2.0 billion, signifies Tryg's commitment to boosting the long-term interests of its shareholders. Understanding the Share Buyback Programme The share buyback programme,...

Continue Reading
ST Imaging's ViewScan Earns 11th Platinum Library Award

Updated Category News Views 122

ST Imaging's ViewScan Reigns Supreme at Modern Library Awards In a remarkable achievement for innovation in library technology, ST Imaging's ViewScan 4 has earned the prestigious Platinum Modern Library Award for the eleventh consecutive year. This award, given by LibraryWorks, celebrates excellence in products designed specifically for library environments, and ST...

Continue Reading
Gilead Sciences Insider Moves Spark Investor Interest

Updated Category News Views 163

Insider Activity at Gilead Sciences: Key Updates Recently, a significant transaction was reported by Jeffrey Bluestone, a Board Member at Gilead Sciences (NASDAQ: GILD). In a filing with the SEC, it was revealed that Bluestone exercised stock options for a total of 5,000 shares. This transaction was valued at $296,250, drawing important attention from investors and market...

Continue Reading